financetom
Business
financetom
/
Business
/
CarMax Q3 Earnings: Solid Growth In Auto Finance Income, Retail And Wholesale Units
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CarMax Q3 Earnings: Solid Growth In Auto Finance Income, Retail And Wholesale Units
Dec 19, 2024 5:33 AM

CarMax, Inc. ( KMX ) shares are trading higher after the company reported third-quarter earnings results.

Quarterly sales of $6.223 billion beat the street view of $6.042 billion. The company reported earnings per share of 81 cents, beating the analyst consensus estimate of 64 cents.

CarMax Auto Finance income was $159.9 million, an increase of 7.6% year over year, driven by an improvement in CAF’s net interest margin percentage and higher average managed receivables.

The provision for loan losses was consistent with expectations set at the end of the second quarter of this year.

Retail used unit sales rose by 5.4% Y/Y, comparable store used unit sales increased by 4.3% Y/Y and wholesale units increased 6.3% Y/Y.

Gross profit per retail used unit was $2,306 (flat Y/Y), and gross profit per wholesale unit was $1,015 (up $54 per unit Y/Y). The Extended Protection Plan margin increased by $53 per retail unit to $573.

In the third quarter of fiscal year 2025, the company repurchased 1.5 million shares of common stock for $114.8 million. As of November 30, 2024, the company had $2.04 billion remaining available for repurchase under the outstanding authorization.

The company exited the quarter with cash and equivalents worth $271.9 million. Restricted cash from collections on auto loans receivable totaled $541.15 million. Inventories at quarter-end was $3.665 billion.

Bill Nash, president and chief executive officer, said, ”Our solid execution and a more stable environment for vehicle valuations enabled us to deliver robust EPS growth driven by increases in unit sales and buys, solid margins, growth in CAF income, and ongoing management of SG&A.” 

During the third quarter of fiscal 2025, the company opened one new store in Alliance, Texas.

Investors can gain exposure to the stock via Valued Advisers Trust Kovitz Core Equity ETF and Invesco Bloomberg Analyst Rating Improvers ETF ( UPGD ) .

Price Action: KMX shares are trading higher by 6.44% to $86.66 premarket at last check Thursday.

Read Next:

CarMax Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street’s Most Accurate Analysts

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BridgeBio Pharma Says Infigratinib Receives US FDA Breakthrough Therapy Designation
BridgeBio Pharma Says Infigratinib Receives US FDA Breakthrough Therapy Designation
Sep 17, 2024
07:57 AM EDT, 09/17/2024 (MT Newswires) -- BridgeBio Pharma ( BBIO ) said Tuesday that the US Food and Drug Administration has granted Breakthrough Therapy Designation to oral infigratinib, which the biopharmaceutical company is developing to treat children with achondroplasia. Shares of BridgeBio Pharma ( BBIO ) were up 1.8% in recent Tuesday premarket activity. Price: 26.75, Change: +0.56, Percent...
Vigil Neuroscience Says FDA Lifts Partial Hold on Phase 1 Trial of Potential Alzheimer's Drug
Vigil Neuroscience Says FDA Lifts Partial Hold on Phase 1 Trial of Potential Alzheimer's Drug
Sep 17, 2024
07:49 AM EDT, 09/17/2024 (MT Newswires) -- Vigil Neuroscience ( VIGL ) said Tuesday that the US Food and Drug Administration has removed the partial hold on its phase 1 clinical trial of VG-3927, a potential therapy for Alzheimer's disease, based on a complete response it submitted to the agency. The company said it has started dosing a group of...
Top Premarket Decliners
Top Premarket Decliners
Sep 17, 2024
07:48 AM EDT, 09/17/2024 (MT Newswires) -- Netcapital ( NCPL ) shares slumped 28% pre-bell Tuesday after the company reported a wider fiscal Q1 loss on lower revenue. Bone Biologics ( BBLG ) shares fell 15%, paring Monday's 136% rally. Dermata Therapeutics ( DRMA ) shares were down 9% after the company priced a $3.5 million private placement of common...
Flow Beverage Q3 Adjusted Loss Narrows as Net Revenue Rises
Flow Beverage Q3 Adjusted Loss Narrows as Net Revenue Rises
Sep 17, 2024
07:54 AM EDT, 09/17/2024 (MT Newswires) -- Flow Beverage ( FLWBF ) on Tuesday said its third-quarter adjusted loss narrowed while net revenue rose slightly. The water company said its adjusted net loss fell to $5.6 million from $12.25 million in the year-ago quarter. Consolidated net revenue rose 5% to $13.8 million. Brand net revenue contracted 15% to $8.4 million,...
Copyright 2023-2025 - www.financetom.com All Rights Reserved